Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: AKV2GM43DD

Pharmacology

Action Mechanism of Action Reference
AGONIST Tumor necrosis factor receptor superfamily member 4 agonist Other PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Melanoma 2 D008545 ClinicalTrials
Prostatic Neoplasms 1 D011471 ClinicalTrials
Lymphoma 1 D008223 ClinicalTrials
Colorectal Neoplasms 1 D015179 ClinicalTrials
Head and Neck Neoplasms 1 D006258 ClinicalTrials
Breast Neoplasms 1 D001943 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2109531
FDA SRS AKV2GM43DD